Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Molecular Partners Ag ADR
(NQ:
MOLN
)
3.600
-0.470 (-11.55%)
Streaming Delayed Price
Updated: 3:49 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Molecular Partners Ag ADR
< Previous
1
2
3
Next >
Molecular Partners to Hold Conference Call to Discuss Fourth Quarter and Full Year 2022 Results and Present at the 43rd Annual Cowen Health Care Conference
March 02, 2023
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Presents New Preclinical Data Supporting Its Radio DARPin Therapy Platform
February 28, 2023
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners to Present at SVB Leerink Global Healthcare Conference
February 10, 2023
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Initiates Clinical Study of Trispecific Candidate MP0533 for the Treatment of Acute Myeloid Leukemia
January 16, 2023
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Provides Updates at 41st Annual JPM Healthcare Conference
January 08, 2023
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Presents New Preclinical Data Supporting its MP0533 DARPin T-Cell Engager for the Treatment of AML
December 12, 2022
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Announces Acceptance of Oral Presentation at the Annual American Society of Hematology Meeting
November 03, 2022
- Company will also host a reception with Key Opinion Leaders in New Orleans -
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Announces Upcoming Participation in Investor and Scientific Conferences
November 02, 2022
From
Molecular Partners
Via
GlobeNewswire
Interim Management Statement Q3 2022: Continued Progress Across Oncology Programs with First Clinical Data Expected from Phase 1 Trial of MP0317 and Initiation of Phase 1 Trial of MP0533 Anticipated by Year-End
October 27, 2022
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners Announces Planned Departure of Chief Financial Officer
October 27, 2022
From
Molecular Partners
Via
GlobeNewswire
Molecular Partners AG (NASDAQ:MOLN) Long Term Investor Alert: Investigation of Potential Wrongdoing
October 26, 2022
San Diego, CA -- (SBWIRE) -- 10/26/2022 -- An investigation was announced for current long-term investors in shares of Molecular Partners AG (NASDAQ:MOLN) concerning potential breaches of fiduciary...
Via
SBWire
NASDAQ:MOLN Investor Notice: Deadline Coming Up on September 12, 2022 in Lawsuit Against Molecular Partners AG
September 12, 2022
San Diego, CA -- (SBWIRE) -- 09/12/2022 -- A deadline is coming up on September 12, 2022 in the lawsuit filed for certain investors of Molecular Partners AG (NASDAQ:MOLN).
Via
SBWire
Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Molecular Partners AG (MOLN) Investors of Class Action and Last Few Hours to Actively Participate
September 12, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
FINAL INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Molecular Partners AG with Losses of $100,000 to Contact the Firm
September 12, 2022
From
The Schall Law Firm
Via
Business Wire
MOLN DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Molecular Partners AG Investors With Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - MOLN
September 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
MOLECULAR PARTNERS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Molecular Partners AG and Encourages Investors to Contact the Firm
September 10, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
September 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
August 27, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
August 24, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
NASDAQ: MOLN Shareholder Notice: Lawsuit Alleges Misleading Statements by Molecular Partners AG
August 16, 2022
San Diego, CA -- (SBWIRE) -- 08/16/2022 -- An investor, who purchased shares of Molecular Partners AG (NASDAQ: MOLN), filed a lawsuit over alleged violations of Federal Securities Laws by Molecular...
Via
SBWire
ROSEN, A LEADING AND RANKED FIRM, Encourages Molecular Partners AG Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
August 12, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
August 07, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
Molecular Partners AG Investigation: Robbins LLP is Investigating Molecular Partners AG (MOLN) on Behalf of Shareholders
July 28, 2022
From
Robbins LLP
Via
Business Wire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
July 24, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
Bronstein, Gewirtz & Grossman, LLC Notifies Molecular Partners AG (MOLN) Investors of Class Action and Encourages Investors to Contact the Firm
July 19, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
INVESTOR NOTICE: Molecular Partners AG Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MOLN
July 18, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
MOLN INVESTOR NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Molecular Partners AG Investors to Secure Counsel Before Important Deadline in Securities Class Action - MOLN
July 16, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Initial Public Offering
Lawsuit
Exposures
COVID-19
Financial
Legal
Shareholder Update: Robbins LLP Reminds Investors of Class Action Against Molecular Partners AG (MOLN)
July 15, 2022
From
Robbins LLP
Via
Business Wire
MOLECULAR PARTNERS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Molecular Partners AG and Encourages Investors to Contact the Firm
July 14, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Molecular Partners AG (MOLN)
July 14, 2022
From
Robbins LLP
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.